Live from the NIH registry
Studies recruiting near Elk Grove right now
Top 25 of 631 recruiting studies, sorted by proximity — each links to its official registry page
Alternation in the Human Microbiome With Commonly Used Topical Medications
Healthy
Phase 1
Interventional 24 participants sought
University of California, Davis, Department of Dermatology — Sacramento, California (12.9 mi)
· Sponsor: University of California, Davis
Cephea Early Feasibility Study
Mitral Regurgitation
N/A
Interventional 90 participants sought
University of California - Davis Medical Center — Sacramento, California (12.9 mi)
· Sponsor: Abbott Medical Devices
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,500 participants sought
Kaiser Permanente-Rancho Cordova Cancer Center — Rancho Cordova, California (12.7 mi)
· Sponsor: NRG Oncology
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC)
Phase 1
Interventional 604 participants sought
University of California, Davis Comprehensive Cancer Center — Sacramento, California (12.9 mi)
· Sponsor: Revolution Medicines, Inc.
Ivonescimab for the Treatment of Thymic Cancer
Thymus Carcinoma
Phase 2
Interventional 25 participants sought
University of California at Davis (UCD) — Davis, California (21.2 mi)
· Sponsor: Jonsson Comprehensive Cancer Center
[68Ga]Ga DOTA-5G as a Diagnostic Imaging Agent for Metastatic/Advanced Invasive Lobular Breast Cancer (LBC)
Metastatic Lobular Breast Carcinoma
Phase 1
Interventional 30 participants sought
University of California Davis — Sacramento, California (12.9 mi)
· Sponsor: University of California, Davis
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms
Phase 3
Interventional 450 participants sought
University of California Davis (UC Davis) Comprehensive Cancer Center — Sacramento, California (12.9 mi)
· Sponsor: Eli Lilly and Company
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
Sutter Institute for Medical Research — Sacramento, California (12.9 mi)
· Sponsor: Medtronic MiniMed, Inc.
Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI)
Amyotrophic Lateral Sclerosis, Neuromuscular Disease
N/A
Interventional 2 participants sought
University of California, Davis — Sacramento, California (12.9 mi)
· Sponsor: Paradromics
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate
Phase 2
Interventional 1,431 participants sought
GMC Clinical Research — Folsom, California (21.3 mi)
· Sponsor: Eli Lilly and Company
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications
Phase 3
Interventional 115 participants sought
University of California Davis Comprehensive Cancer Center (Adults only) — Sacramento, California (12.9 mi)
· Sponsor: Pierre Fabre Medicament
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Mercy Cancer Center - Elk Grove — Elk Grove, California (0.8 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma
Phase 3
Interventional 5,951 participants sought
Sutter Medical Center Sacramento — Sacramento, California (12.9 mi)
· Sponsor: Children's Oncology Group
Magnesium Infusion for Pain Management in Critically Ill Trauma Patients
Trauma, Acute Pain
Phase 4
Interventional 156 participants sought
UC Davis Health — Sacramento, California (12.9 mi)
· Sponsor: University of California, Davis
Complex Adult Deformity Surgery (CADS)
Adult Spinal Deformity, Scoliosis
N/A
Observational 1,500 participants sought
University of California, Davis, Department of Orthopedic Surgery — Sacramento, California (12.9 mi)
· Sponsor: International Spine Study Group Foundation
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Carcinoma
Phase 3
Interventional 804 participants sought
Mercy Cancer Center - Elk Grove — Elk Grove, California (0.8 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Childhood Medulloblastoma
Phase 3
Interventional 225 participants sought
University of California Davis Comprehensive Cancer Center — Sacramento, California (12.9 mi)
· Sponsor: Children's Oncology Group
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Heart Failure
Phase 3
Interventional 1,500 participants sought
CON-10024 Sacramento, CA Investigational Site — Sacramento, California (12.9 mi)
· Sponsor: Colorado Prevention Center
ACX-362E [Ibezapolstat] for Oral Treatment of Recurrent Clostridioides Difficile Infection
Clostridium Difficile Infection Recurrence
Phase 2
Interventional 20 participants sought
UC Davis Medical Center — Sacramento, California (12.9 mi)
· Sponsor: Acurx Pharmaceuticals Inc.
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
Mercy Cancer Center - Elk Grove — Elk Grove, California (0.8 mi)
· Sponsor: NRG Oncology
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
Retinal Consultants Med Group — Sacramento, California (12.9 mi)
· Sponsor: Genentech, Inc.
Nutrition for Precision Health, Powered by the All of Us
Nutrition, Health
N/A
Interventional 8,000 participants sought
University of California, Davis — Davis, California (21.2 mi)
· Sponsor: RTI International
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)
Anarthria, Dysarthria
N/A
Interventional 2 participants sought
University of California, Davis — Sacramento, California (12.9 mi)
· Sponsor: Leigh R. Hochberg, MD, PhD.
Narrow Excision Versus Wide Excision for the Treatment of Adults With Invasive Cutaneous Melanoma, ICEMAN Trial
Clinical Stage IA Cutaneous Melanoma AJCC v8, Clinical Stage IB Cutaneous Melanoma AJCC v8
N/A
Interventional 1,000 participants sought
University of California, Davis — Davis, California (21.2 mi)
· Sponsor: OHSU Knight Cancer Institute
Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma
Open Angle Glaucoma (OAG)
N/A
Interventional 165 participants sought
Sacramento Eye Consultants — Sacramento, California (12.9 mi)
· Sponsor: Avisi Technologies Inc.